Moderna Awarded $590 Million for Bird Flu Vaccine Development
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...
This virus was named Influenza B and the inactivated influenza ... became the technique that was used by commercial manufacturers. A vaccine was manufactured according to this procedure ...
However, as the demand for seasonal influenza vaccination in the general population has failed to meet the expectations of suppliers, oversupply of these vaccines in the United States has become ...
With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...
Why You Need A Flu Vaccine Every Year The phenomena of antigenic drift and antigenic shift are why public health authorities recommend getting an influenza vaccine each year. Every year ...
Influenza vaccine is effective for preventing severe influenza illness among children, according to a study published online Dec. 27 in JAMA Network Open. Kelsey M. Sumner, Ph.D., M.S.P.H., from ...
The historical role of the British city of Liverpool as a trading port has helped it to become a center of excellence for vaccine manufacturing.
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback